• About us
• Contact

Advertisement

Person › Details

Robert LaCaze (Bayer Pharma division)

LaCaze, Robert (Bayer 201702–202202 EVP of new Oncology Strategic Business Unit joined 2015 from BMS LEFT 2/22)

 

	Organisation	Bayer Pharma division
	Group	Bayer (Group)
	Product	cancer drug
	Product 2	oncology

Record changed: 2022-02-07

Advertisement

More documents for Robert LaCaze

• [1] Bayer AG. (7/31/19). "Press Release: U.S. FDA Approves Darolutamide, a New Treatment for Men with Non-metastatic Castration-resistant Prostate Cancer [Not intended for U.S. and UK Media]". Berlin....
• [2] Foundation Medicine, Inc.. (5/29/19). "Press Release: Bayer and Foundation Medicine Announce Global Collaboration To Develop Next-generation Sequencing (NGS)-based Companion Diagnostics In Oncology". Cambridge, MA & Berlin....
• [3] Bayer AG / Bayer Corporation. (2/15/19). "Press Release: Bayer to Obtain Full Rights to Global Development and Commercialization of Oncology Compounds Vitrakvi (larotrectinib) and BAY 2731954 (LOXO-195)". Whippany, NJ....
• [4] Bayer Corporation. (11/26/18). "Press Release: FDA Approves Vitrakvi (larotrectinib), the First Ever TRK Inhibitor, for Patients with Advanced Solid Tumors Harboring an NTRK Gene Fusion". Whippany, NJ & Stamford, CT....
• [5] Loxo Oncology, Inc.. (11/14/17). "Press Release: Loxo Oncology Announces Global Development and Commercialization Partnership with Bayer for Larotrectinib and LOXO-195". Stamford, CT....
• [6] Bayer AG. (7/21/17). "Press Release: Phase II Trial of Investigational Anetumab Ravtansine Does Not Meet Primary Endpoint in Second-Line Mesothelioma [Not intended for U.S. and UK Media]". Berlin....
• [7] Bayer AG. (5/17/17). "Press Release: Bayer Receives FDA Priority Review For Investigational Anti-Cancer Compound Copanlisib [Not intended for U.S. and UK Media]". Berlin....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.